What Uscom does

Uscom Limited (ASX: UCM) is an Australian medical technology company founded in 1999 and headquartered in Sydney that develops, manufactures, and globally markets non-invasive cardiovascular and pulmonary monitoring devices. The company's three core product suites are the USCOM 1A (a Doppler-based hemodynamic monitor that measures cardiac output across aortic or pulmonary valves and works regardless of patient rhythm or ventilation status), the BP+ (a central blood pressure monitor using patent-protected suprasystolic oscillometry to directly measure aortic pressure waveforms), and the SpiroSonic Suite (digital multi-path ultrasonic spirometers with no moving parts, no proprietary disposables, and Bluetooth/cloud connectivity). Companion software platforms (BP+ Reporter and SpiroReporter) provide data archiving, waveform analysis, and reporting functionality, with HL7-compliant EMR integration available on the USCOM 1A.

Uscom operates a distributor-led go-to-market model through approximately 35 regional distributors across 50+ countries, anchored by wholly-owned regional subsidiaries in Beijing (China), Budapest (Europe), and Singapore (SE Asia). Revenue is generated primarily through hardware sales of medical devices, supplemented by companion software and recurring distributor stocking orders. The company holds multiple regulatory approvals including CE Mark (BP+), FDA (USCOM 1A), CFDA (USCOM 1A), TGA ARTG (SpiroSonic), and US GSA Schedule listing for federal/VA/state government sales. Target clinical segments include critical care/ICU, hypertension and heart failure management, pulmonary/respiratory care, maternal medicine, and pediatric/neonatal care, with named deployments including the US Naval Base San Diego, US Veterans Affairs Medical Centers, the Public Health Agency of Catalonia, and Aqsitania SAS for French lung transplant monitoring. The business is supported by over 500 peer-reviewed clinical publications validating USCOM 1A clinical utility and is pursuing further geographic and product-line expansion via a Foxconn manufacturing partnership in China, an Eurostars-funded smart spacer development program, and new USCOM Basic/Classic/Advance variants tailored for Chinese market tendering.

Name

Uscom

Legal name

Uscom Limited

Website

https://uscom.com.au

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Uscom Limited (ASX: UCM) is an Australian medical technology company that develops and globally distributes non-invasive cardiovascular and pulmonary monitoring devices (USCOM 1A, BP+, SpiroSonic) via approximately 35 regional distributors serving critical care, hypertension, and respiratory clinical segments across 50+ countries.

Ownership category

akta.pro rank

Product category

Non-invasive Cardiovascular & Pulmonary Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industries

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Pulse Oximeters & Respiratory Monitors (Consumer) (CRACAQAF)

Keywords

• Non-invasive hemodynamic monitoring
• Cardiac output monitoring devices
• Central blood pressure monitors
• Digital ultrasonic spirometry
• Medical Doppler devices

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations

Revenue model

1. Medical Device Sales: Sale of USCOM 1A hemodynamic monitors, BP+ central blood pressure monitors, and SpiroSonic spirometers. Products sold through distributor network globally. Multiple regulatory approvals (CE, FDA, CFDA, TGA) enabling sales in various jurisdictions.
2. Software Solutions: Companion software including BP+ Reporter for archiving, analysis and reporting, and SpiroReporter for pulmonary function data management.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Uscom designs, manufactures, and globally distributes three suites of non-invasive premium medical monitoring devices: the USCOM 1A Doppler-based cardiac output and hemodynamic monitor; the BP+ suprasystolic oscillometric central blood pressure monitor; and the SpiroSonic family of digital multi-path ultrasonic spirometers. Products are sold to hospitals, clinics, government health systems, and home-care programs through a network of approximately 35 regional medical device distributors across 50+ countries.

Product overview

Uscom is an Australian medical technology company specializing in non-invasive cardiovascular and pulmonary monitoring devices. The company offers three core product suites: the USCOM 1A advanced hemodynamic monitor (Doppler-based cardiac output monitoring), the BP+ central blood pressure monitor (suprasystolic oscillometric technology with companion BP+ Reporter software), and the SpiroSonic Suite of digital multi-path ultrasonic spirometers (with FLO, AIR, SMART variants and SpiroReporter software). Additional sub-products include USCOM Basic, Classic, and Advance variants developed for the Chinese market. These premium devices are designed for clinical and home care settings, focusing on cardiovascular disease, hypertension, heart failure, sepsis management, and pulmonary conditions including asthma, COPD, and sleep disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• USCOM 1A Advanced non-invasive hemodynamic monitor using Doppler technology to measure cardiac blood flow, stroke volume, and cardiac output across the aortic or pulmonary valve. Used in sepsis, heart failure, hypertension, and fluid management across neonatal, pediatric, critical care, emergency, perioperative, oncological, maternal, and perinatal populations.
• BP+ Non-invasive central blood pressure monitor using suprasystolic oscillometry to measure BP and pulse pressure waves directly at the heart (central BP) and in the arm. Performs Pulse Waveform Analysis (PWA), measures arterial stiffness, augmentation index, and pulse rate variability. Used in hypertension, heart failure, vascular health, and critical care.
• SpiroSonic Suite Digital multi-path ultrasonic spirometers (FLO, AIR, SMART variants) for pulmonary function testing using high-fidelity multi-path ultrasound. Requires no daily calibration, has no moving parts, and uses no proprietary disposables. Features Bluetooth connectivity, automated interpretation, and diagnostic decision support.
• SpiroSonic tSpiro Advanced multi-path ultrasonic spirometer with telemetric wireless connectivity for remote digital monitoring and cloud-based pulmonary function analysis, designed for home care and remote patient monitoring.
• USCOM Basic

Quantifiable outcome

• 95% appropriate fluid use vs 50% baseline when using USCOM 1A for fluid management
• +4 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and strategic.

• Foxconn (Beijing)coreStrategic or Co-development Partner · 1 January 2022Manufacturing and R&D partnership in Beijing for USCOM devices. New facilities completed with NMPA regulatory requirements progressing. New devices USCOM Basic, Classic, and Advance developed for Chinese market to address 'Made in China by 2025' regulation requiring local manufacturing.
• CIIC Shanghai Science and TechnologycoreChannel Partner/ Reseller/ DistributorChinese state-owned importation and wholesale partner for Uscom devices into China market. Responsible for CFDA regulatory process and distribution through Sense Medical network across 32 provinces.
• Pacific Medical Systems (PMS)coreChannel Partner/ Reseller/ DistributorMaster medical device distributor for SE Asia covering Thailand, Hong Kong, Macau, Singapore, Taiwan, Malaysia, and Indonesia. Long-term Uscom partner since USCOM 1A release. 3-year distribution agreement for BP+ and BP+ Reporter with ~AU$1.5M revenue target over 3 years.
• Mr Ng Jih NangcoreOthersSE Asian Distribution and Business Development Manager with 20+ years Asian medical technology sales and BD experience with GE, Leica, Philips, Teleflex. Based in new Singapore Regional HQ covering ASEAN, Japan, South Korea, China, and Indian subcontinent.
• Aqsitania SASstrategicStrategic or Co-development PartnerFrench eHealth company partnership for lung transplant monitoring using ~100 SpiroSonic tSpiro devices. Second phase anticipated to order several hundred devices. Supported by European Union funding.
• Sonmedica S.A.strategicStrategic or Co-development PartnerSpanish digital health partnership with Public Health Agency of Catalonia and University of Barcelona Health Campus. Nextcare Digital Health Care Project delivering telemetric pulmonary care using SpiroSonic tSpiro devices. First worldwide implementation of telemetric pulmonary care in eHealth home care model.
• Eurostars ProgrammestrategicStrategic or Co-development PartnerEuropean research grant consortium awarded 1,317,502 Euro (~AU$1.86M) over 2 years for smart spacer development. Uscom receiving 349,480 Euro (~AU$492k) for pulmonary recovery training and drug uptake research. Collaboration with Dutch pulmonary specialists.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• nSpire Health: nSpire Health is a specialist manufacturer of pulmonary function testing and spirometry equipment and competes head-to-head with Uscom's SpiroSonic suite across clinical and research spirometry use cases.
• AtCor Medical (now CardieX / SphygmoCor): AtCor Medical's SphygmoCor is the historical gold-standard device for non-invasive central aortic blood pressure measurement and the most direct competitor to Uscom's BP+ in the central blood pressure and pulse-wave-analysis category.
• Edwards Lifesciences: Edwards Lifesciences is the dominant player in invasive and minimally invasive hemodynamic monitoring through its FloTrac/Vigileo, ClearSight, and VolumeView platforms and is the most direct competitor to Uscom's USCOM 1A Doppler-based cardiac output monitor. Both companies target ICU, OR, and ED fluid management and sepsis protocols.
• Cheetah Medical: Cheetah Medical (acquired by Baxter) commercializes the NICOM non-invasive cardiac output monitor using bioreactance technology — a direct competitive alternative to USCOM 1A for non-invasive hemodynamic monitoring in critical care environments.

Broad incumbents

• Philips Healthcare: Philips is a broad incumbent in multi-parameter patient monitoring (IntelliVue) and EMR-integrated vital-signs platforms; while not specialized in Uscom's specific Doppler/oscillometry niches, its enterprise monitoring strategy competes for the same hospital capital budget and clinician mindshare.
• Dräger: Dräger's Infinity and Perseus patient monitoring platforms are established incumbents in critical-care monitoring and anesthesia, with overlapping hemodynamic and respiratory monitoring positioning that competes for ICU and OR placements against Uscom.
• Masimo: Masimo is a broad incumbent in non-invasive patient monitoring (pulse oximetry, rainbow SET, and connected bedside monitoring) and competes with Uscom's vital signs monitoring and EMR-connected device philosophy via its hospital automation and tele-monitoring offerings.
• GE Healthcare: GE Healthcare's CARESCAPE patient monitoring platform addresses the same critical-care hemodynamic and respiratory monitoring use cases as Uscom's USCOM 1A and SpiroSonic, and benefits from broad multi-modality enterprise sales coverage.
• Nihon Kohden: Nihon Kohden is a broad incumbent in multi-parameter bedside patient monitoring, neurology, and cardiology, with established hemodynamic and respiratory monitoring offerings that overlap with Uscom's USCOM 1A and SpiroSonic portfolios across Asian hospital accounts.

Emerging players

• Mindray: Mindray is a China-headquartered emerging global player in patient monitoring, in-vitro diagnostics, and medical imaging; it is the most direct local competitor inside China and increasingly competes in emerging markets where Uscom distributes through Sense Medical and CIIC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/uscom
• Facebookfacebook.com/uscomlimited
• LinkedInlinkedin.com/company/uscom

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uscom